Concarlo Holdings' Unattributed Round

Concarlo Holdings raised a round of funding on March 23, 2017.

Concarlo Holdings is developing solutions for drug-resistant breast cancer. Using its patent technologies, the company can increase drug efficacy and diagnostic evaluations for ER/PR+ Her 2- patients.…

Articles about Concarlo Holdings' Unattributed Round: